Enfermedad Inflamatoria Intestinal al Día最新文献_第3页

Evolución del conocimiento de la fisiopatología de la enfermedad inflamatoria intestinal 炎症性肠病病理生理学知识的发展

Enfermedad Inflamatoria Intestinal al Día Pub Date : 2017-01-01 DOI: 10.1016/j.eii.2016.04.003

Y. Zabana Abdo

引用次数: 3

El papel de enfermería en una unidad monográfica de enfermedad inflamatoria intestinal, una visión de 360° 护理在炎症性肠病专题单元中的作用，360°视角

Enfermedad Inflamatoria Intestinal al Día Pub Date : 2017-01-01 DOI: 10.1016/j.eii.2016.09.004

E. Navarro

{"title":"El papel de enfermería en una unidad monográfica de enfermedad inflamatoria intestinal, una visión de 360°","authors":"E. Navarro","doi":"10.1016/j.eii.2016.09.004","DOIUrl":"10.1016/j.eii.2016.09.004","url":null,"abstract":"<div><p>The WHO is advocating for the educational paradigm of self-care, led essentially by nursing professionals due to their clinical profile and training. There are few studies which value the role of the nurse in multidisciplinary units for patients with Inflammatory Bowel Disease (IBD). Our goal is to show the different views of the role and competencies of nursing in the IBD Unit at Vall d’Hebron Hospital.</p><p>A qualitative study, critical theory. The ethnographic method (microethnographic), from a descriptive focus. Semi-structured and registered personalised interviews through the use of webcams and voice registration. The codification and analysis of the information was undertaken manually. Of 10 participants, 8 collaborated. The connection to the UACC Unit is between one to twelve years.</p><p>Roles highlighted: case management, training, coordination, nurse availability and finally, the role of investigation, existing differences according to the link to the unit.</p><p>In analysis by competency we find: knowledge of inflammatory disease, chronic diseases, pharmacology and knowledge of the role of nursing. Skills: Communication, advocacy, management of chronic patients and stress, grouping, and empathy. Attitudes: listening, openness, calming, educational and receptive.</p><p>Knowing how nurses are considered permits opportunities for change, and this leads to setting out new lines of research which demonstrate the benefits of nurse management in IBD units.</p></div>","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2016.09.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76746973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

Un enfoque práctico para el manejo de la enfermedad perianal de Crohn compleja 一种处理复杂克罗恩肛周疾病的实用方法

Enfermedad Inflamatoria Intestinal al Día Pub Date : 2017-01-01 DOI: 10.1016/j.eii.2016.09.001

A. García García de Paredes, C. Ferre Aracil, E. Rodríguez de Santiago, L. Aguilera Castro, A. López-San Román

引用次数: 0

WITHDRAWN: Telemedicina en el manejo de pacientes con enfermedad inflamatoria intestinal drawn:炎症性肠病患者的远程医疗管理

Enfermedad Inflamatoria Intestinal al Día Pub Date : 2016-12-27 DOI: 10.1016/J.EII.2016.10.001

J. D. Hoyo, M. Aguas

引用次数: 0

Nutrición enteral en el paciente adulto con enfermedad inflamatoria intestinal 成人炎症性肠病患者的肠内营养

Enfermedad Inflamatoria Intestinal al Día Pub Date : 2016-09-01 DOI: 10.1016/j.eii.2016.06.002

I. Bretón , C. Carbonell

引用次数: 0

Nutrición enteral en el paciente pediátrico con enfermedad de Crohn 小儿克罗恩病患者的肠内营养

Enfermedad Inflamatoria Intestinal al Día Pub Date : 2016-09-01 DOI: 10.1016/j.eii.2016.06.003

V.M. Navas-López , J. Van Limbergen , J. Martín-de-Carpi

引用次数: 3

Manejo práctico de la intensificación del tratamiento biológico en los pacientes con enfermedad inflamatoria intestinal 炎症性肠病患者生物治疗强化的实际管理

Enfermedad Inflamatoria Intestinal al Día Pub Date : 2016-09-01 DOI: 10.1016/j.eii.2016.04.004

J.M. Paredes, E. Moreno-Osset

{"title":"Manejo práctico de la intensificación del tratamiento biológico en los pacientes con enfermedad inflamatoria intestinal","authors":"J.M. Paredes, E. Moreno-Osset","doi":"10.1016/j.eii.2016.04.004","DOIUrl":"10.1016/j.eii.2016.04.004","url":null,"abstract":"<div><p>Biological treatment with drugs targeting tumor necrosis factor-α (anti-TNF) has improved the therapeutic options for inflammatory bowel disease (IBD). These drugs have shown high clinical efficacy associated primarily with mucosal healing and improvement in the patient́s quality of life. However, a high percentage of patients do not respond to initial treatment or lose the achieved response over time. To prevent or attenuate anti-TNF failure, several strategies have been employed in an attitude known as treatment intensification. These strategies include: increasing anti-TNF dosage, shortening the intervals in administration, associating anti-TNF to an immunomodulator or, although not strictly an attitude of intensification, switching to another anti-TNF or biological drug (there are few alternatives in IBD). These strategies are usually applied empirically, based on the clinical condition of patients. Recently, the introduction of anti-TNF monitoring in clinical practice through the determination of drug serum levels and presence of antibodies to the drug, allows a more accurate selection of strategies. Nevertheless, there are certain aspects of the intensification of anti-TNF treatment that remain unresolved and patients with intensified treatment must be closely and thoroughly monitored because of the high risk of infection.</p></div>","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2016.04.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75838243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Requerimientos terapéuticos en el tratamiento de mantenimiento de la proctitis ulcerosa 溃疡性直肠炎维持治疗的治疗要求

Enfermedad Inflamatoria Intestinal al Día Pub Date : 2016-09-01 DOI: 10.1016/j.eii.2016.05.003

M. Calafat , T. Lobatón , M. Mañosa , M. Larraín , N. Caballero , E. Cabré , E. Domènech

{"title":"Requerimientos terapéuticos en el tratamiento de mantenimiento de la proctitis ulcerosa","authors":"M. Calafat , T. Lobatón , M. Mañosa , M. Larraín , N. Caballero , E. Cabré , E. Domènech","doi":"10.1016/j.eii.2016.05.003","DOIUrl":"10.1016/j.eii.2016.05.003","url":null,"abstract":"<div><h3>Introduction</h3><p>In population-based studies, ulcerative proctitis (UP) accounts for more than 25% of ulcerative colitis (UC) patients and presents distinctive clinical outcomes and therapeutic approaches as compared to left-sided and extensive UC. Our aim was to describe the different therapeutic approaches and health resources used in patients with UP in clinical remission.</p></div><div><h3>Material and methods</h3><p>We performed a retrospective observational study including patients with UP that were followed in our Hospital Universitari Germans Trias i Pujol between 1989-2014. Clinical information and the different treatments for the maintenance of remission were recorded, including galenical formulation.</p></div><div><h3>Results</h3><p>A total of 101 patients with UP were included. Median time of follow up was 8 years (IQR 3-14). Most patients were treated with topical mesalazine (especially suppositories) (89%); followed by oral mesalazine (55%). The 33% of patients underwent combined therapy with oral and topical mesalazine. Another 12% were treated with topical steroids for maintenance therapy and 3% of patients required thiopurines. The 10% of patients attended to Emergency Service and 4% were hospitalized for disease activity within follow-up. None of them required colectomy.</p></div><div><h3>Conclusions</h3><p>Topical mesalazine is the most used maintenance treatment in UP patients in our clinical practice, suggesting both a good acceptance by patients and a high degree of confidence for doctors. UP is associated with a low requirement of health resources, although studies focused on the quality of life are needed.</p></div>","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2016.05.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88999558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Momento 一会儿

Enfermedad Inflamatoria Intestinal al Día Pub Date : 2016-09-01 DOI: 10.1016/j.eii.2016.09.003

J. Hinojosa, I. Marín-Jiménez

引用次数: 0

Lesiones por el virus del papiloma humano en un paciente con colitis ulcerosa bajo terapia inmunosupresora: a propósito de un caso 免疫抑制治疗下溃疡性结肠炎患者的人乳头状瘤病毒损伤:病例综述

Enfermedad Inflamatoria Intestinal al Día Pub Date : 2016-09-01 DOI: 10.1016/j.eii.2016.05.002

M.A. Arriola, B. Iade, X. Pazos

引用次数: 0